Condition
Spleen; Fibrosis
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
66.7%
2 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Terminated2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05122416Not ApplicableTerminatedPrimary
Optimization of Spleen VCTE Examinations with FibroScan
NCT05899309Unknown
Precision Medicine to Predict the Trajectory of Liver Cirrhosis: Prospective Cohort Study
NCT03896607Terminated
Liver and the Spleen Stifness in Adult Patients With Gaucher's Disease Using Ultrasound Shear Wave Elastography
Showing all 3 trials